Michael Flanagan

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Bristol Myers Squib
    Topic:
    Mavacamten use in obstructive HFM
    Date added:
    10/14/2025
    Date updated:
    10/14/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Cytokinetics
    Topic:
    Aficamten use in obstructive HCM
    Date added:
    10/14/2025
    Date updated:
    10/14/2025
Return to Oct. 18, 2025 - Pediatric Sudden Cardiac Death Symposium